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Objective: Electrical impedance myography (EIM) is a method for evaluating muscle in which high-frequency, low-intensity alternating
current is applied to a body region and the resulting surface voltage pattern over a muscle of interest is measured. In this study, the
reproducibility for the simplest of these techniques, 50 kHz linear-EIM, was assessed for three muscles.
Methods: Fifty kilohertz linear-EIM was performed on the biceps, quadriceps, and tibialis anterior of 30 normal subjects ranging in age from
21 to 90 years, and the major outcome variable, the spatially averaged phase (qavg), measured. The measurements were repeated within
250 days and comparisons between the two data sets made.
Results: Reproducibility, as measured by the intraclass correlation coefficients for all three muscles, was very high at 0.970, 0.971, and 0.938
for biceps, quadriceps, and tibialis anterior, respectively. Variability between measurements was on average 4.2% for all muscle combined,
with an upper limit of 16.8%.
Conclusions: Fifty kilohertz linear-EIM demonstrates excellent test–retest reproducibility.
Significance: These results support the view that 50 kHz linear-EIM has the potential to be used as a simple, fast, and non-invasive
measurement for the assessment of disease status, either as part of individual patient care or as a surrogate outcome measure in clinical trials
work.
q 2006 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.
Keywords: Electrical impedance; Reproducibility; MuscleElectrical impedance myography (EIM) is a method of
neuromuscular evaluation in which high-frequency, low-
intensity alternating current is passed through muscle tissue
and the consequent surface voltage patterns assessed
(Aaron and Shiffman, 2000; Shiffman et al., 1999).
Although still in development, data thus far has shown it
to reveal potentially valuable information about muscle
condition, including changes in muscle health that occur
over time, either due to aging or to disease status. For
example, we have shown that EIM can be useful in rapidly
assessing inflammatory muscle disease severity, a problemlinical Neurophysiology.
1 617 667 8747.
utkove).that is not easily addressed using conventional electro-
myography techniques (Rutkove et al., 2002; Tarulli et al.,
2005). In addition, we have been able to identify
differences in EIM data in patients with radiculopathy,
possibly eventually leading to EIM as a new non-invasive
test for assessing focal neurogenic disorders (Rutkove
et al., 2005a,b). A number of variations of EIM are in
development, the simplest being what we have called
50 kHz linear-EIM, in which 50 kHz current is supplied at
a distance from an array of voltage electrodes placed over a
muscle region of interest (Rutkove et al., 2002). For
example, a voltage electrode array may be placed along the
long axis of the quadriceps on one side with current-
injecting electrodes placed on both feet.Clinical Neurophysiology 117 (2006) 1244–1248www.elsevier.com/locate/clinphPublished by Elsevier Ireland Ltd. All rights reserved.
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which measures impedance associated with the passage of
current through intra- and extra-cellular fluids, and the
reactance (X), which directly reflects the impedance of the
cell membranes. Whereas all tissues underlying the voltage
electrodes, including subcutaneous fat and bone, could in
principle contribute to the impedance signature, both fat and
bone have markedly higher resistivities (Faes et al., 1999).
Accordingly, when the current electrodes are placed far
from the voltage electrode array, as in this work, virtually all
the electrical current in the regions near the voltage
electrode array travels through the muscle tissue. Further-
more, given sufficiently high detector input impedance,
essentially no current flows through the voltage-electrode/
skin–fat layer interface, and changes in the measured X and
R accurately reflect conditions of the underlying muscle.
Detailed analysis of the method have been given in
Shiffman et al. (1999) and Rutkove et al. (2005a,b), but
how the changes in R and X relate to the underlying
histology and physiology of the muscle remains uncertain
and is the subject of ongoing study.
R and X can be evaluated independently, but both depend
on the shape and cross-sectional area of the tissue. However,
these dependences tend to cancel in the calculation of the
primary outcome measure, the phase (q), calculated via the
equation qZarctan X/R (Shiffman et al., 1999). Because
measurements are performed using a series of electrodes
overlying the limb, the simplest way of summarizing the
data is by obtaining a mathematical average, which is
designated qavg.
Although initial work involved only measurements over
the quadriceps (Rutkove et al., 2002), we have since
expanded the methodology to evaluate a variety of other
muscles. In this report, we investigate the reproducibility of
the 50 kHz linear-EIM technique for the three muscles we
have studied the most: biceps, quadriceps, and tibialis
anterior (TA).1. Methods
1.1. Normal subjects
Healthy subjects were recruited by advertisement and by
pre-screening of hospital employees. Exclusion criteria
included: age less than 18 years, the presence of a
pacemaker, pregnancy, or dialysis. Subjects were also
excluded if there was a history of weakness, sensory
complaints, or neuromuscular disease in any form,
including radiculopathy. In addition, all subjects underwent
detailed physical examination and needle electromyography
(EMG) of the muscles under study. If abnormalities were
found during the screening evaluation, subjects were
excluded. Informed consent was obtained for all subjects,
and studies were performed with institutional review board
approval from Beth Israel Deaconess Medical Center.1.2. 50 kHz Linear-EIM technique
Impedance data were obtained using either a modified
RJL Model 101-A instrument (RJL Electronics, Clinton
Township, MI), which supplied a constant 0.8 mA current
at a fixed frequency of 50 kHz, (Shiffman et al., 1999) or a
Signal Recovery model 7280 DSP lock-in amplifier
(Ametek Advanced Measurement Technology, Inc, Old
Woking, Surrey, UK) with frequency set to 50 kHz and
current supplied from the 1 volt reference channel output
and measured using a non-inductive 20 O resistor. The
second system was developed more recently and is capable
of multifrequency measurements, and it has supplanted the
earlier system for most of our recent work. Hence, the
choice of system used for each patient depended on
whether that individual participated recently or when the
study was initiated. The two systems were calibrated
against the same resistor capacitor network designed to
mimic the behavior of typical muscle tissue; in human
testing, measurements using both systems differed by about
5%, testifying to the robustness of the technique. However,
since test and retest measurements made on each subject
were performed using the same device, any systematic
difference between the two instruments has virtually no
consequence in the present context. In both cases resistance
and reactance are defined as the in-phase and 908-out-of-
phase components of the ratio DV/I, respectively, where
DV is the measured voltage difference between the selected
voltage electrodes of the array, and I is the current flowing
through the limb.
Current was introduced using 20 cm2 Nicolet Disposable
Ground Plate Electrodes (part number 019-400500, Viasys
Healthcare/Nicolet Biomedical, Madison, WI) on the
dorsum of both feet (for quadriceps and TA) and palm of
both hands (for biceps). Voltage sensing was performed via
disposable 5.5 mm wide strip electrodes (part number 019-
766400, Viasys Healthcare/Nicolet Biomedical, Madison,
WI), cut to lengths of 4.5 cm. Measurements were made
with the subject lying on an examination table with the
knees bent at a small angle and the arm supinated and
minimally abducted at the shoulder.
After the skin was cleaned with alcohol, voltage
electrodes were placed along a line parallel to the limb
axis overlying the greatest muscle bulk. For biceps, the first
voltage electrode (V1) was placed 2.5 cm proximal to the
middle point of the antecubital fossa, with the five
subsequent electrodes placed 2.5 cm apart in a line along
the anterior surface of the biceps. For quadriceps, V1 was
placed 5 cm proximal to the patella with seven subsequent
electrodes (V2–V8) placed 2.5 cm apart in a line along the
anterior thigh extending proximally. For TA, V6 was placed
2.5 cm distal to the midpoint between the top of the tibia and
the fibular head, with V5 through V1 placed 2.5 cm apart in
a line along the belly of the muscle along the anterior
foreleg.
Fig. 2. Test versus retest reproducibility of qavg for quadriceps. ICC,
intraclass correlation coefficient.
S.B. Rutkove et al. / Clinical Neurophysiology 117 (2006) 1244–12481246Switching between electrodes and various instrument
settings was under computer control, and digital signals
representing R and X were transmitted to the computer for
display and further processing. In particular, graphs of R and
X versus z, the distance along the voltage electrode array,
were produced; values of the phase, q(z), and its spatial
average, qavg, were then calculated (Shiffman et al., 1999,
2001).
1.3. Reproducibility measurements
For the purposes of this study, subjects were asked to
return for repeat testing anywhere from 7 to 250 days after
the initial measurements. A broad time range was chosen so
as to better understand real-world changes in EIM
measurement as compared to a more artificial test–retest
situation in which measurements are taken only several days
apart. At the time of revisit, a brief history was obtained to
determine if there was any substantial change in the
individual’s health status, if there had been a change in
his/her exercise routines or activity level over the
intervening weeks, or if any new medications had been
initiated. Individuals who did not report a change in status
then underwent repeat testing of the muscles previously
studied. Two research assistants trained in the technique
performed all the studies, with each doing the repeated
measurements on the same subject.2. Results
A total of 30 normal subjects (16 men and 14 women,
mean age 52.4 years, range 21–90 years) participated in the
test–retest program. The average time between measure-
ments was 113 days (range 7–239 days). The results for the
three muscles are shown in Figs. 1–3 as plots of test versus
retest values of qavg, together with least-squares-fitted lines
pinned to the origin. As seen, the slopes of the lines are all
very close to 1, with that figure representing perfectFig. 1. Test versus retest reproducibility of qavg for biceps. ICC, intraclass
correlation coefficient.reproducibility. Also, the intraclass correlation coefficients
for all three muscles are very high, being 0.970 for biceps,
0.971 for quadriceps, and 0.938 for TA. Table 1 provides
data for the overall values for each of the measurements,
their variability, expressed as mean % difference between
measurements, and the standard deviation and range of
those differences. Fig. 4 shows the % change as a histogram
combining the data for all three muscles.
Despite a substantial variation in the interval between
measurements, there was no meaningful correlation
between the time interval and the degree of variability
(R2Z0.060).3. Discussion
The degree of reproducibility of 50 kHz linear-EIM that
is observed in this study is comparable to or substantially
exceeds what is found in other electrophysiological tests of
muscle and nerve. For example, in nerve conduction
measurements, median F-wave latencies exhibit test–retestFig. 3. Test versus retest reproducibility of qavg for tibialis anterior. ICC,
intraclass correlation coefficient.
Table 1
Summary of test–retest reproducibility data





Quadriceps 10.0 9.93 4.16 3.12 K11.9 to C11.4
Biceps 6.63 6.62 4.71 4.27 K8.7 to C16.8
Tibialis Anterior 9.11 9.05 4.92 3.85 K15.7 to C11.9
Fig. 4. Histogram demonstrating cumulative amount of variation in the 3
muscles studied.
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variables perform far worse, such as motor and sensory
amplitudes, which can show variation greater than 50%
(Kimura, 1997). There are virtually no studies evaluating
reproducibility of needle electromyography, although a
single study (published only in abstract form) suggests a
inter-rater reliability amongst experienced clinicians of only
about 60% (Kendall and Werner, 2004). It also appears that
linear-EIM has a similar or slightly higher test–retest
reproducibility than motor unit number estimation tech-
niques, in which correlation coefficients of 0.85–0.98 have
been reported (Shefner, 2001).
As an aside, one question that may arise is whether or not
we can be certain that the measurements reflect only the
characteristics of the muscle immediately underlying the
voltage electrodes. Indeed, we cannot. Rather the EIM
signature likely reflects the impedance of all the tissues
underlying the voltage electrodes, albeit with the major
contribution from the muscle(s) immediately beneath them.
We anticipate that future enhancements, mainly involving
the method of electrical current application, will make it
possible to obtain impedance data relevant to only a single
muscle of interest. In addition, while at present, our practice
has been to rely on standard anatomic landmarks for the
placement of electrodes, the incorporation of surface
electromyographic data or contraction-induced impedance
changes to assist with electrode placement is also being
pursued.
The aim of this study was to assess the reproducibility of
linear-EIM under conditions which reflected realistic
clinical conditions, and there are several factors which
will likely limit the reproducibility in such situations,
amongst which accurate repositioning of the electrodes is
perhaps the most important. The effects of errors in
electrode placement has been studied in detail (Rutkove
et al., 2005a,b), evaluating differences in phase due to
medial–lateral and distal–proximal shifts of the voltage
electrode array, or of its orientation relative to the limb axis.
It was estimated there that the limiting practical reprodu-
cibility would be no better than a few percent, insofar as
such factors are concerned. Applying the voltage electrode
array in the ‘identical position’ in the test and re-test
sessions is not trivial, despite having established procedures,
and it is gratifying to see from Fig. 4 that close to the
estimated practical limit has been achieved. Of course,
shifts in phase may also emanate from other sources, such as
minor inconsistencies in limb position, differences inhydration, or other genuine physiological changes between
sessions.
Another clinically realistic aspect of this study was our
choice to not specify an exact interval between measure-
ments, except to say that it should be no less than 7 days and
no more than 250 days. It is possible that had smaller time
intervals been chosen such as 1–2 days, as is frequently
done in test–retest studies, the reproducibility may have
been higher, but in our view this represents a much more
artificial assessment. Whereas we found only a very weak
relationship between test–retest shifts and the length of time
interval between sessions, it is still possible that the longer
intervals could have contributed to a small extent to the
observed variation.
EIM remains very much in development, and it is likely
that further advances in the technique will lead to
improvements in the reproducibility and the ability to study
smaller muscles, rather than the large muscles studied here.
Clearly, pre-fabricated electrode arrays would make accurate
electrode repositioning much easier. For studies where even
minor changes are important, digital photography of the
voltage electrode array together with a distance measure
would also be helpful, and if truly critical, a small tattoo
could be applied to assist with exact repositioning of the
array. Minor changes such as these could make substantial
improvements in the ability to detect very small changes in
neuromuscular disease status. Clearly, the greater the
reproducibility, the greater will be the value of the technique
in the assessment of individual patients undergoing treatment
and as a surrogate outcome measure in clinical trials work.
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